Parvovirus B19 in pregnancy
Exam relevance: in 10 of more than 150 board exam reports · rank 66
- Synonyms
- fifth disease, slapped cheek
- Specialty
- Obstetrics · Pregnancy disorders
- Images
- Ultrasound 1
- Exam relevance
- 10 of more than 150 reports · rank 66
- In the app
- 1 flashcard · GynFuchs
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (1)
Definition
Pathogen and Clinical Presentation
- In children, the disease is called: fifth disease, i.e., erythema infectiosum.
- Typical in children: malar erythema, lacy exanthem.
- What the virus attacks: erythroid progenitor cells.
- The fetus is therefore at risk of: aplastic anaemia, hydrops fetalis.
- Predominant in adults: arthralgia, flu-like course.
- The child is contagious: before the exanthem appears.
- Parvovirus B19 infection in pregnancy is a maternal infection with the agent of erythema infectiosum (fifth disease) that can be transmitted transplacentally to the fetus.
Occurrence & epidemiology
Epidemiology
- At the start of pregnancy, 34–65% of pregnant women are not immune, depending on the population studied.
Aetiopathogenesis
Aetiology and pathogenesis
- The virus is transmitted via respiratory secretions, hand-to-mouth contact, blood products and transplacentally.
- Fetal tissues, including haematopoietic cells and myocardium, express the viral P antigen receptor, which mainly explains anaemia and hydrops.
- The rate of transmission to the fetus is 17–33%.
- The fetus is most at risk in the first and second trimesters; after 20 weeks of gestation the risk of hydrops is 1% or less.
Clinical features
Clinical features and complications
- In immunocompetent adults, infection is usually asymptomatic or mild; maternal manifestations include erythema infectiosum, arthropathy, anaemia and thrombocytopenia.
- Fetal consequences include anaemia, thrombocytopenia, myocarditis, effusions, non-immune hydrops and intrauterine death; however, most infected fetuses remain unaffected.
Diagnosis
Fetal Monitoring
- The crucial measurement is: PSV in the middle cerebral artery (MCA).
- What causes it to increase in anaemia: lower blood viscosity.
- Threshold for a suspected diagnosis of severe anaemia: PSV increase above 1.5 MoM.
- Other signs on ultrasound: ascites, effusions, skin & placental edema.
- Maternal diagnosis is based on IgG and IgM antibodies; IgM is detectable from the end of the first week of infection.
- Fetal infection is detected by PCR of amniotic fluid.
- A middle cerebral artery peak systolic velocity above 1.5 MoM is highly suggestive of moderate to severe fetal anaemia.
- Ultrasound signs of hydrops are ascites, skin oedema, pleural and pericardial effusions and placental oedema.
Treatment principles
- There is no antiviral treatment; after confirmed maternal infection, the fetus is monitored by ultrasound and Doppler for several weeks for anaemia and hydrops.
- In severe fetal anaemia, intrauterine transfusion in a specialist centre is the treatment of choice.
- Without signs of fetal involvement, the prognosis is good and delivery is not required on these grounds.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Placenta accreta spectrum · Placenta praevia · Placental insufficiency
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.
